Quetiapine treatment in patients with posttraumatic stress disorder: an open trial of adjunctive therapy / Mark B. Hamner en Journal of Clinical Psychopharmacology, Año 2003 - Vol. 23 - No. 1 (Febrero)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2003 - Vol. 23 - No. 1 (Febrero) . - pp. 15-20 Título : Quetiapine treatment in patients with posttraumatic stress disorder: an open trial of adjunctive therapy Tipo de documento: texto impreso Autores: Mark B. Hamner, Autor ; Sarah E. Deitsch, Autor ; Peter S. Brodrick, Autor Fecha de publicación: 2023 Artículo en la página: pp. 15-20 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antipsicóticos, Dibenzotiacepinas, Fumarato de quetiapina, Trastornos de estrés postraumático, Trastornos relacionados con sustancias. Resumen: In this 6-week, open-label trial, combat veterans meeting DSM-IV criteria for posttraumatic stress disorder (PTSD) were treated with the atypical antipsychotic quetiapine. The starting dose was 25 mg at bedtime with subsequent titration based on tolerability and clinical response. Primary outcome was measured using the Clinician Administered PTSD Scale (CAPS). Link: ./index.php?lvl=notice_display&id=31039 [artículo] Quetiapine treatment in patients with posttraumatic stress disorder: an open trial of adjunctive therapy [texto impreso] / Mark B. Hamner, Autor ; Sarah E. Deitsch, Autor ; Peter S. Brodrick, Autor . - 2023 . - pp. 15-20. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2003 - Vol. 23 - No. 1 (Febrero) . - pp. 15-20 Palabras clave: Antipsicóticos, Dibenzotiacepinas, Fumarato de quetiapina, Trastornos de estrés postraumático, Trastornos relacionados con sustancias. Resumen: In this 6-week, open-label trial, combat veterans meeting DSM-IV criteria for posttraumatic stress disorder (PTSD) were treated with the atypical antipsychotic quetiapine. The starting dose was 25 mg at bedtime with subsequent titration based on tolerability and clinical response. Primary outcome was measured using the Clinician Administered PTSD Scale (CAPS). Link: ./index.php?lvl=notice_display&id=31039

---

1 (1 - 1 / 1)